11-68936560-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002180.3(IGHMBP2):​c.2080C>T​(p.Arg694Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.221 in 1,611,560 control chromosomes in the GnomAD database, including 42,150 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R694Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.20 ( 3353 hom., cov: 33)
Exomes 𝑓: 0.22 ( 38797 hom. )

Consequence

IGHMBP2
NM_002180.3 missense

Scores

5
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.319

Publications

30 publications found
Variant links:
Genes affected
IGHMBP2 (HGNC:5542): (immunoglobulin mu DNA binding protein 2) This gene encodes a helicase superfamily member that binds a specific DNA sequence from the immunoglobulin mu chain switch region. Mutations in this gene lead to spinal muscle atrophy with respiratory distress type 1. [provided by RefSeq, Jul 2008]
IGHMBP2 Gene-Disease associations (from GenCC):
  • autosomal recessive distal spinal muscular atrophy 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • Charcot-Marie-Tooth disease axonal type 2S
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hereditary peripheral neuropathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005527556).
BP6
Variant 11-68936560-C-T is Benign according to our data. Variant chr11-68936560-C-T is described in ClinVar as Benign. ClinVar VariationId is 258567.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.243 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IGHMBP2NM_002180.3 linkc.2080C>T p.Arg694Trp missense_variant Exon 13 of 15 ENST00000255078.8 NP_002171.2 P38935

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IGHMBP2ENST00000255078.8 linkc.2080C>T p.Arg694Trp missense_variant Exon 13 of 15 1 NM_002180.3 ENSP00000255078.4 P38935

Frequencies

GnomAD3 genomes
AF:
0.201
AC:
30599
AN:
152002
Hom.:
3352
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.170
Gnomad AMI
AF:
0.307
Gnomad AMR
AF:
0.209
Gnomad ASJ
AF:
0.280
Gnomad EAS
AF:
0.0297
Gnomad SAS
AF:
0.0678
Gnomad FIN
AF:
0.124
Gnomad MID
AF:
0.203
Gnomad NFE
AF:
0.246
Gnomad OTH
AF:
0.255
GnomAD2 exomes
AF:
0.188
AC:
46754
AN:
249024
AF XY:
0.187
show subpopulations
Gnomad AFR exome
AF:
0.179
Gnomad AMR exome
AF:
0.185
Gnomad ASJ exome
AF:
0.276
Gnomad EAS exome
AF:
0.0294
Gnomad FIN exome
AF:
0.132
Gnomad NFE exome
AF:
0.247
Gnomad OTH exome
AF:
0.219
GnomAD4 exome
AF:
0.224
AC:
326345
AN:
1459440
Hom.:
38797
Cov.:
62
AF XY:
0.219
AC XY:
159223
AN XY:
725868
show subpopulations
African (AFR)
AF:
0.174
AC:
5802
AN:
33386
American (AMR)
AF:
0.186
AC:
8291
AN:
44598
Ashkenazi Jewish (ASJ)
AF:
0.278
AC:
7242
AN:
26076
East Asian (EAS)
AF:
0.0308
AC:
1223
AN:
39682
South Asian (SAS)
AF:
0.0782
AC:
6742
AN:
86216
European-Finnish (FIN)
AF:
0.134
AC:
7028
AN:
52644
Middle Eastern (MID)
AF:
0.223
AC:
1284
AN:
5762
European-Non Finnish (NFE)
AF:
0.248
AC:
275690
AN:
1110778
Other (OTH)
AF:
0.216
AC:
13043
AN:
60298
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
15088
30177
45265
60354
75442
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9212
18424
27636
36848
46060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.201
AC:
30602
AN:
152120
Hom.:
3353
Cov.:
33
AF XY:
0.194
AC XY:
14419
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.170
AC:
7055
AN:
41492
American (AMR)
AF:
0.209
AC:
3189
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.280
AC:
972
AN:
3466
East Asian (EAS)
AF:
0.0298
AC:
154
AN:
5174
South Asian (SAS)
AF:
0.0672
AC:
324
AN:
4822
European-Finnish (FIN)
AF:
0.124
AC:
1319
AN:
10600
Middle Eastern (MID)
AF:
0.201
AC:
59
AN:
294
European-Non Finnish (NFE)
AF:
0.246
AC:
16718
AN:
67962
Other (OTH)
AF:
0.252
AC:
532
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1243
2486
3730
4973
6216
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
316
632
948
1264
1580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.230
Hom.:
17714
Bravo
AF:
0.211
TwinsUK
AF:
0.248
AC:
921
ALSPAC
AF:
0.245
AC:
945
ESP6500AA
AF:
0.174
AC:
766
ESP6500EA
AF:
0.248
AC:
2129
ExAC
AF:
0.188
AC:
22756
Asia WGS
AF:
0.0700
AC:
248
AN:
3478
EpiCase
AF:
0.249
EpiControl
AF:
0.255

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jul 17, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 19% of total chromosomes in ExAC -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive distal spinal muscular atrophy 1 Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Apr 14, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease Benign:1
-
Molecular Genetics Laboratory, London Health Sciences Centre
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive distal spinal muscular atrophy 1;C4015349:Charcot-Marie-Tooth disease axonal type 2S Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease axonal type 2S Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
17
DANN
Uncertain
1.0
DEOGEN2
Benign
0.18
T
Eigen
Benign
-0.67
Eigen_PC
Benign
-0.72
FATHMM_MKL
Benign
0.38
N
LIST_S2
Benign
0.41
T
MetaRNN
Benign
0.0055
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Uncertain
2.2
M
PhyloP100
0.32
PrimateAI
Benign
0.43
T
PROVEAN
Uncertain
-2.4
N
REVEL
Benign
0.19
Sift
Uncertain
0.0030
D
Sift4G
Uncertain
0.060
T
Polyphen
0.013
B
Vest4
0.047
MPC
0.20
ClinPred
0.038
T
GERP RS
3.5
PromoterAI
-0.20
Neutral
Varity_R
0.071
gMVP
0.34
Mutation Taster
=89/11
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2236654; hg19: chr11-68704028; COSMIC: COSV54820138; COSMIC: COSV54820138; API